https://www.live-feeds.com/feed/astrazeneca-hopes-to-achieve-amazing-things-with-new-kendall-square-r-d-centerContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/astrazeneca-hopes-to-achieve-amazing-things-with-new-kendall-square-r-d-centerhttps://www.live-feeds.com/feed/astrazeneca-hopes-to-achieve-amazing-things-with-new-kendall-square-r-d-center#u111655Fri, 09 Oct 2026 09:55:46 +0000AstraZeneca opened a new research and development center in Cambridge, Massachusetts, anchoring a $1 billion investment in the state. The biopharmaceutical company plans to expand its local workforce by more than 50 percent as part of the initiative. The facility in Kendall Square utilizes robots to conduct scientific operations and was designed by architectural firms HOK and Pickard Chilton to foster collaboration and discovery. Chief Executive Officer Pascal Soriot noted that the company does not need a deal for growth beyond 2030.Why it mattersThe new facility establishes a major corporate